Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models
Somatic mutations affect key pathways in lung adenocarcinoma
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
Lists
0
_(cropped).jpg/500px-National_Cancer_Institute_director_Harold_E._Varmus_(3)_(cropped).jpg)
.png/500px-American_Academy_of_Arts_and_Sciences_(ancient_logo).png)
